tiprankstipranks
Trending News
More News >
Advertisement

RSMV - ETF AI Analysis

Compare

Top Page

RSMV

Relative Strength Managed Volatility Strategy ETF 1Shs (RSMV)

Rating:64Neutral
Price Target:
The ETF RSMV's overall rating reflects a balanced mix of strengths and risks across its holdings. Strong contributors like Merck (MRK) and Johnson & Johnson (JNJ) drive the fund's rating with their robust financial performance, strategic growth initiatives, and positive earnings outlooks. However, weaker holdings such as AbbVie (ABBV) and Philip Morris (PM) weigh on the score due to concerns about overvaluation, bearish momentum, and financial stability risks. The fund's diversification helps mitigate risks, but investors should note potential vulnerabilities from holdings with high leverage or valuation concerns.
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including Technology, Health Care, and Consumer Defensive, which helps reduce risk from sector-specific downturns.
Healthy Recent Performance
The fund has shown steady gains over the year-to-date and three-month periods, indicating strong recent momentum.
Exposure to Leading Companies
Top holdings include well-established companies like Apple and Adobe, which are leaders in their industries.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which could eat into investor returns over time.
Underperforming Holdings
Some key holdings, such as Adobe and UnitedHealth, have struggled with weak year-to-date performance, potentially dragging on overall returns.
Heavy U.S. Focus
With over 83% of its assets in U.S. companies, the fund lacks significant global diversification, making it more sensitive to domestic market conditions.

RSMV vs. SPDR S&P 500 ETF (SPY)

RSMV Summary

The Relative Strength Managed Volatility Strategy ETF (RSMV) is designed to invest in companies across the total market that show strong performance compared to their peers, with a focus on growth and managing risk. It includes well-known companies like Adobe and Apple, and covers sectors such as technology, healthcare, and consumer goods. This ETF might appeal to investors looking for growth opportunities while aiming to reduce volatility in their portfolio. However, new investors should be aware that its performance can fluctuate with the overall market, and its focus on growth stocks may make it more sensitive to economic changes.
How much will it cost me?The Relative Strength Managed Volatility Strategy ETF (RSMV) has an expense ratio of 0.95%, which means you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it’s actively managed, meaning the fund managers are making strategic decisions to optimize growth and manage risk rather than simply tracking a market index.
What would affect this ETF?The RSMV ETF, with strong exposure to sectors like Technology and Health Care, could benefit from continued innovation and consumer demand in these areas, as well as a stable U.S. economy. However, it may face challenges if interest rates rise, potentially impacting growth-focused companies, or if regulatory changes affect key holdings like Apple and Adobe. Additionally, market volatility could influence performance despite the fund's managed volatility strategy.

RSMV Top 10 Holdings

The Relative Strength Managed Volatility ETF (RSMV) leans heavily into health care and technology, with names like Eli Lilly and Cisco driving steady performance thanks to strong earnings and strategic growth initiatives. Johnson & Johnson adds stability with its bullish outlook, while AbbVie shows mixed signals, balancing robust R&D investments against valuation concerns. On the downside, T-Mobile and Philip Morris are lagging, with bearish momentum and competitive pressures weighing on returns. With a U.S.-focused portfolio, the fund’s positioning reflects a blend of innovation and resilience, though some holdings are struggling to keep pace.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
8.32%$3.19M
4.54%$1.74M
Broadcom2.39%$915.21K$1.90T148.62%
76
Outperform
Merck & Company2.31%$885.69K$260.19B3.14%
76
Outperform
Alphabet Class A2.30%$881.46K$3.86T89.51%
80
Outperform
Alphabet Class C2.30%$880.77K$3.86T87.76%
82
Outperform
Meta Platforms2.26%$864.88K$1.63T12.82%
71
Outperform
Tesla2.23%$854.01K$1.43T24.63%
73
Outperform
American Express2.22%$850.23K$251.62B19.89%
81
Outperform
Eli Lilly & Co2.22%$849.24K$1.02T35.22%
71
Outperform

RSMV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
26.90
Positive
100DMA
26.21
Positive
200DMA
25.10
Positive
Market Momentum
MACD
0.09
Negative
RSI
61.54
Neutral
STOCH
99.67
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSMV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.02, equal to the 50-day MA of 26.90, and equal to the 200-day MA of 25.10, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 61.54 is Neutral, neither overbought nor oversold. The STOCH value of 99.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RSMV.

RSMV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$38.33M0.95%
$88.20M0.75%
$54.75M0.60%
$50.41M0.70%
$50.28M0.56%
$41.75M0.50%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RSMV
Relative Strength Managed Volatility Strategy ETF 1Shs
27.51
2.02
7.92%
AOTG
AOT Growth and Innovation ETF
SEMG
Suncoast Select Growth ETF
HGRO
Hedgeye Quality Growth ETF
GROZ
Zacks Focus Growth ETF
RILA
Indexperts Gorilla Aggressive Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement